Literature DB >> 12654965

FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts.

H Topaloglu1, M Brockington, Y Yuva, B Talim, G Haliloglu, D Blake, S Torelli, S C Brown, F Muntoni.   

Abstract

BACKGROUND: Congenital muscular dystrophies (CMD) are autosomal recessive disorders that present within the first 6 months of life with hypotonia and a dystrophic muscle biopsy. CNS involvement is present in some forms. The fukutin-related protein gene (FKRP) is mutated in a severe form of CMD (MDC1C) and a milder limb girdle dystrophy (LGMD2I). Both forms have secondary deficiencies of laminin alpha2 and alpha-dystroglycan immunostaining. Structural brain involvement has not been observed in patients with FKRP gene mutations.
METHODS: The authors studied two unrelated patients who had a pattern of muscle involvement identical to MDC1C, mental retardation, and cerebellar cysts on cranial MRI. The FKRP gene was analyzed along with the skeletal muscle expression of laminin alpha2 and alpha-dystroglycan.
RESULTS: The muscle biopsy of both patients showed severe dystrophic findings, a reduction in laminin alpha2, and profound depletion of alpha-dystroglycan. Both patients had homozygous FKRP gene mutations not previously reported (C663A [Ser221Arg] and C981A [Pro315Thr]).
CONCLUSIONS: Mutations within the FKRP gene can result in CMD associated with mental retardation and cerebellar cysts. This adds structural brain defects to the already wide spectrum of abnormalities caused by FKRP mutations. The severe depletion of alpha-dystroglycan expression suggests that FKRP is involved in the processing of alpha-dystroglycan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654965     DOI: 10.1212/01.wnl.0000052996.14099.dc

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies.

Authors:  Xiaona Fu; Haipo Yang; Cuijie Wei; Hui Jiao; Shuo Wang; Yanling Yang; Chunxi Han; Xiru Wu; Hui Xiong
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

Review 2.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

Review 3.  Malformations of cortical development and epilepsy.

Authors:  A James Barkovich; William B Dobyns; Renzo Guerrini
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

Review 4.  Extracellular matrix functions during neuronal migration and lamination in the mammalian central nervous system.

Authors:  Santos J Franco; Ulrich Müller
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

5.  Ataxia, intellectual disability, and ocular apraxia with cerebellar cysts: a new disease?

Authors:  Andrea Poretti; Martin Häusler; Arpad von Moers; Bastian Baumgartner; Klaus Zerres; Andrea Klein; Chiara Aiello; Francesca Moro; Ginevra Zanni; Filippo M Santorelli; Thierry A G M Huisman; Joachim Weis; Enza Maria Valente; Enrico Bertini; Eugen Boltshauser
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 6.  Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.

Authors:  Paul T Martin
Journal:  Nat Clin Pract Neurol       Date:  2006-04

Review 7.  The dystroglycanopathies: the new disorders of O-linked glycosylation.

Authors:  Paul T Martin
Journal:  Semin Pediatr Neurol       Date:  2005-09       Impact factor: 1.636

8.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

9.  B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.

Authors:  Paul J Thomas; Rui Xu; Paul T Martin
Journal:  Am J Pathol       Date:  2016-09       Impact factor: 4.307

10.  New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.

Authors:  Nacim Louhichi; Chahnez Triki; Susana Quijano-Roy; Pascale Richard; Samira Makri; Mériem Méziou; Brigitte Estournet; Slah Mrad; Norma B Romero; Hammadi Ayadi; Pascale Guicheney; Faiza Fakhfakh
Journal:  Neurogenetics       Date:  2003-12-02       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.